Cargando…

Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis

Background: Glioblastoma (GBM) is the most aggressive type of primary malignant brain tumor. Carmustine is used by intravenous injection or local implantation in the resection cavity for gliomas, including GBMs. However, the therapeutic potential of carmustine is not well-recognized. This analysis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zhi-Ze, Wang, Ze-Fen, Lan, Tian, Huang, Wen-Hong, Zhao, Yu-Hang, Ma, Chao, Li, Zhi-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527463/ https://www.ncbi.nlm.nih.gov/pubmed/33041980 http://dx.doi.org/10.3389/fneur.2020.01036

Ejemplares similares

Systemic Inflammatory Indicators as Prognosticators in Glioblastoma Patients: A Comprehensive Meta-Analysis
por: Yang, Chao, et al.
Publicado: (2020)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation
por: Zhao, Yu-Hang, et al.
Publicado: (2019)

Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
por: Manini, Ivana, et al.
Publicado: (2022)

Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Jilani, Kashif, et al.
Publicado: (2013)

Symptomatic cerebral vasospasm in the setting of carmustine wafer placement for glioblastoma: A case presentation and review of literature
por: Khan, Maheen Qamar, et al.
Publicado: (2020)

Presence of Atrial Fibrillation in Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis
por: Chen, Jessie Ze-Jun, et al.
Publicado: (2021)

Downregulation of Leucine-Rich Repeat-Containing 8A Limits Proliferation and Increases Sensitivity of Glioblastoma to Temozolomide and Carmustine
por: Rubino, Sebastian, et al.
Publicado: (2018)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

The Clinical Significance of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis
por: Zhao, Yu-Hang, et al.
Publicado: (2018)

Recent Advances and Therapeutic Options in Lambert-Eaton Myasthenic Syndrome
por: Anwar, Arsalan, et al.
Publicado: (2019)

MPC-03 IMMUNOHISTOCHEMICAL ANALYSIS OF TUMOR ASSOCIATED MACROPHAGE INDUCED AFTER BIODEGRADABLE CARMUSTINE WAFER IMPLANTATION IN HUMAN GLIOBLASTOMA
por: Shibahara, Ichiyo, et al.
Publicado: (2019)

Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers
por: Yang, Chao, et al.
Publicado: (2022)

Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients with Glioblastoma: A Comprehensive Study Based on Meta-Analysis and Retrospective Single-Center Analysis
por: Yang, Chao, et al.
Publicado: (2022)

Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic and Psychiatric Illnesses
por: Habib, Sara, et al.
Publicado: (2018)

The Role of Neuroinflammation in Glaucoma: An Update on Molecular Mechanisms and New Therapeutic Options
por: Rolle, Teresa, et al.
Publicado: (2021)

Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma
por: Li, Jie, et al.
Publicado: (2021)

Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic Diseases and Psychiatric Disorders: A Systematic Review
por: Ozturk, Huseyin, et al.
Publicado: (2022)

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
por: Chowdhary, Sajeel A., et al.
Publicado: (2015)

Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis
por: Camara-Lemarroy, Carlos R., et al.
Publicado: (2018)

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
por: Almikhlafi, Mohannad A., et al.
Publicado: (2023)

Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
por: Pan, Zhi-Yong, et al.
Publicado: (2019)

Editorial: Complex Scenarios of Drug-Resistant Epilepsies: Diagnostic Challenges and Novel Therapeutic Options
por: Didato, Giuseppe, et al.
Publicado: (2022)

Effectiveness of Lomustine Combined With Bevacizumab in Glioblastoma: A Meta-Analysis
por: Ren, Xing, et al.
Publicado: (2021)

Glioblastoma fed by middle meningeal artery and displaying cyst formation soon after repeated implantation of carmustine wafers: A case report
por: Yamamuro, Shun, et al.
Publicado: (2017)

Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis
por: Zhong, Jiugen, et al.
Publicado: (2022)

Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: A systematic review and meta-analysis
por: Kang, Zhiran, et al.
Publicado: (2022)

The brain structure and function abnormalities of migraineurs: A systematic review and neuroimaging meta-analysis
por: Chen, Zhu-Hong, et al.
Publicado: (2022)

A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma
por: Pritha, Ariana, et al.
Publicado: (2022)

Assessing Response Using (99m)Tc-MIBI Early after Interstitial Chemotherapy with Carmustine-Loaded Polymers in Glioblastoma Multiforme: Preliminary Results
por: Cecchin, D., et al.
Publicado: (2014)

Is Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective against Local Recurrence of Glioblastoma? A Pharmacokinetic Study by Measurement of BCNU in the Tumor Resection Cavity
por: Ohnishi, Takanori, et al.
Publicado: (2022)

Secondary White Matter Injury and Therapeutic Targets After Subarachnoid Hemorrhage
por: Ru, Xufang, et al.
Publicado: (2021)

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells
por: Thamilselvan, Vijayalakshmi, et al.
Publicado: (2012)

Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson's disease: a cross-sectional and 3-year longitudinal cohort study
por: Kikuchi, Akio, et al.
Publicado: (2013)

Robotic Arm Rehabilitation in Chronic Stroke Patients With Aphasia May Promote Speech and Language Recovery (but Effect Is Not Enhanced by Supplementary tDCS)
por: Buchwald, Adam, et al.
Publicado: (2018)

Supplementary Motor Area and Superior Parietal Lobule Restore Sensory Facilitation Prior to Stepping When a Decrease of Afferent Inputs Occurs
por: Lhomond, Olivia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c5vhqg3er198kki7le03taabv4